DE:978 Stock Latest News
Company AnnouncementsAdagene Doses First Patient in Phase 1 Study of ADG1382d ago6KADAG
Company AnnouncementsAdagene, City of Hope Launch Phase 1 Colorectal Cancer Trial4d ago6KADAG
Company AnnouncementsAdagene Completes Enrollment in Phase 2 Muzastotug Trial1w ago6KADAG
Company AnnouncementsAdagene Announces Finance Executive Resignation Effective September 30, 20261M ago6KADAG
Company AnnouncementsAdagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG1382M ago6KADAG
Company AnnouncementsAdagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected2M ago6KADAG
The FlyAdagene initiated with a Buy at Chardan2M agoADAG
Company AnnouncementsAdagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration2M ago6KADAGCompany AnnouncementsAdagene Extends Cash Runway and Advances Muzastotug Through Mid-2026 Clinical Milestones3M ago6KADAG
Company AnnouncementsAdagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 20264M ago6KADAG
Company AnnouncementsAdagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers7M ago6KADAG







